Changes to our trading names and address – MSD and Organon & Co. read more

Changes to our trading names and address

Please note that in 2021, MSD will be spinning off products from its women’s health, legacy brands, and biosimilars franchises into a new independent, publicly traded company known as Organon & Co.

Due to legal entity separation in advance of this spin off, we now have two UK registered businesses, MSD and Organon. Organon & Co. is a wholly owned subsidiary of Merck & Co., Inc. of Kenilworth, New Jersey, USA.

As a result of the future spin-off of Organon, as well as our head offices moving to London in early 2021, you will begin to see some changes to references to our products, contact details, materials and statements over the coming months.

Your questions answered:How MSD is responding to the global pandemic, COVID-19

COVID-19 is an extraordinary challenge to the global community. In the face of this unprecedented challenge, we would like to extend our sincere appreciation to all those who are going above and beyond to do their part in helping affected patients and communities, especially the NHS, healthcare workers and volunteers who are on the front-line of this fight.

As a company dedicated to saving and improving lives, MSD recognises that we have a special responsibility to help. MSD remains focused on protecting the safety of its employees and their families, assuring the supply and manufacture of medicines and vaccines for our patients and populations, contributing our scientific expertise to the development of antiviral approaches, and supporting our healthcare providers and the communities in which they serve.

Thanks to our teams and colleagues, our manufacturing plants and clinical supply sites remain open around the world and, we are taking steps to make sure that continues to be the case.

We know many of you have questions and we want to answer them as best as we can. To help you navigate your questions, we’re providing the list of FAQs below:

Does MSD have medicines or vaccines for COVID-19? If not, is MSD developing any medicines and vaccines to help combat COVID-19?
How is COVID-19 impacting MSD clinical trials?
How is MSD protecting employees and health care providers?
How is MSD supporting relief efforts for COVID-19?
How do we reach the media team at MSD?
How can we stay up to date on COVID-19?
How can I find out more about product supply?

Job code: GB-NON-03884Date of preparation: February 2021

  • News Room